PAD: Medtronic Files For FDA Approval Of Drug-Eluting Balloon
Medtronic files the 1st module of a pre-market approval application with the FDA for its In.Pact Admiral drug-eluting balloon to treat peripheral artery disease. Medtronic (NYSE:MDT) applied for pre-market approval from the FDA for a medical device designed to treat peripheral artery disease, the In.Pact Admiral drug-eluting balloon. Fridley, Minn.-based Medtronic said it’s gearing up for a…